Search Result for 'cancer treatment'

21. July 2024 BASF Microfluidic preparation and optimization of Kollicoat ® IR-b-PCL polymersome for co-delivery of Nisin-Curcumin in breast cancer ...

et al., 2023b), a potential source of anti-cancer glutamic acid (Jain et al., 2022). Clinically, the combination of iron oxide-coated ...

Chitosan Excipient nanoparticles as cancer therapeutics: Mechanistic actions, delivery and manufacturing perspectives 22. June 2025 Drug Delivery Microneedles as Gateways: ...

of therapeutic agents, enhancing drug bioavailability at tumor sites while minimizing systemic side effects. The integration of NPs into MN ...

Chemicals Ltd Gujarat, India. Padakanti Sandeep Chary, Ankush Bansode, Naveen Rajana, Valamla Bhavana, Siva Singothu, Anamika Sharma, Santosh Kumar Guru, ...

use on approval date* 48. Ubrelvy ubrogepant 12/23/2019 Acute treatment of migraine with or without aura in adults Press Release ...

It was a pioneering concept in the 1980s and found its way to clinical use over the last three decades. ...

Abstract: Salinomycin (Sal) is a potent inhibitor with effective anti-breast cancer properties in clinical therapy. The occurrence of various side ...

Abstract Background: Cervical cancer is the second most commonly diagnosed cancer worldwide and the third leading cause of death among ...

for advanced skin cancer therapy. The findings underscore the potential translational impact of these nanocarriers, paving the way for future ...